Schneider G - Search Results

1

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1.

Beyer M, Romanski A, Mustafa AM, Pons M, Büchler I, Vogel A, Pautz A, Sellmer A, Schneider G, Bug G, Krämer OH. Beyer M, et al. Among authors: schneider g. Cancers (Basel). 2019 Sep 26;11(10):1436. doi: 10.3390/cancers11101436. Cancers (Basel). 2019. PMID: 31561534 Free PMC article.

2

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

Schneider G, Krämer OH, Fritsche P, Schüler S, Schmid RM, Saur D. Schneider G, et al. J Cell Mol Med. 2010 Jun;14(6A):1255-63. doi: 10.1111/j.1582-4934.2009.00974.x. Epub 2009 Nov 19. J Cell Mol Med. 2010. PMID: 19929947 Free PMC article. Review.

3

NFκB/p53 crosstalk-a promising new therapeutic target.

Schneider G, Krämer OH. Schneider G, et al. Biochim Biophys Acta. 2011 Jan;1815(1):90-103. doi: 10.1016/j.bbcan.2010.10.003. Epub 2010 Oct 15. Biochim Biophys Acta. 2011. PMID: 20951769 Review.

4

Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Schneider G, Krämer OH, Schmid RM, Saur D. Schneider G, et al. J Gastrointest Cancer. 2011 Jun;42(2):85-92. doi: 10.1007/s12029-011-9257-1. J Gastrointest Cancer. 2011. PMID: 21271301 Review.

5

The importin-alpha/nucleophosmin switch controls taspase1 protease function.

Bier C, Knauer SK, Docter D, Schneider G, Krämer OH, Stauber RH. Bier C, et al. Among authors: schneider g. Traffic. 2011 Jun;12(6):703-14. doi: 10.1111/j.1600-0854.2011.01191.x. Epub 2011 Apr 13. Traffic. 2011. PMID: 21418451 Free article.

6

A ZEB1-HDAC pathway enters the epithelial to mesenchymal transition world in pancreatic cancer.

Schneider G, Krämer OH, Saur D. Schneider G, et al. Gut. 2012 Mar;61(3):329-30. doi: 10.1136/gutjnl-2011-301576. Epub 2011 Dec 5. Gut. 2012. PMID: 22147511 No abstract available.

7

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.

Stauber RH, Knauer SK, Habtemichael N, Bier C, Unruhe B, Weisheit S, Spange S, Nonnenmacher F, Fetz V, Ginter T, Reichardt S, Liebmann C, Schneider G, Krämer OH. Stauber RH, et al. Among authors: schneider g. Oncotarget. 2012 Jan;3(1):31-43. doi: 10.18632/oncotarget.430. Oncotarget. 2012. PMID: 22289787 Free PMC article.

8

MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.

Labisso WL, Wirth M, Stojanovic N, Stauber RH, Schnieke A, Schmid RM, Krämer OH, Saur D, Schneider G. Labisso WL, et al. Among authors: schneider g. Cell Cycle. 2012 Apr 15;11(8):1593-602. doi: 10.4161/cc.20008. Epub 2012 Apr 15. Cell Cycle. 2012. PMID: 22456335

9

Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.

Brandl A, Wagner T, Uhlig KM, Knauer SK, Stauber RH, Melchior F, Schneider G, Heinzel T, Krämer OH. Brandl A, et al. Among authors: schneider g. J Mol Cell Biol. 2012 Oct;4(5):284-93. doi: 10.1093/jmcb/mjs013. Epub 2012 Apr 5. J Mol Cell Biol. 2012. PMID: 22493095

10

Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells.

Bier C, Hecht R, Kunst L, Scheiding S, Wünsch D, Goesswein D, Schneider G, Krämer OH, Knauer SK, Stauber RH. Bier C, et al. Among authors: schneider g. PLoS One. 2012;7(5):e34142. doi: 10.1371/journal.pone.0034142. Epub 2012 May 3. PLoS One. 2012. PMID: 22570686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,930 results

Search Page